Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Pharmaceutical Business Review
Return to: PBR Home
Top Headlines

Pharmaceutical Business Review

Asterias, Cancer Research UK ink deal for new lung cancer vaccine Asterias Biotherapeutics, a subsidiary of BioTime, has entered into an agreement with Cancer Research Technology (CRT), Cancer Research UK's development and commercialization arm, to evaluate its AST-VAC2 in a clinical trial as an immunotherapy to treat patients with non-small cell lung cancer (NSCLC). Contract Research & Services > Clinical Trials > News
Lupin and Merck Serono enter into strategic alliance By PBR Staff Writer
Lupin and Merck Serono have entered into a strategic partnership to support the latter to broaden its general medicines portfolio in emerging markets.
Drug Research > Drug Discovery & Development > News Akashi Therapeutics acquires global rights to GsMTx-4 compound By PBR Staff Writer
Clinical stage biopharmaceutical company Akashi Therapeutics has received global rights to GsMTx-4, a peptide developed by Tonus Therapeutics to address calcium level imbalance in muscle.
Contract Research & Services > Contract Research > News Roche commences phase III clinical trials for lampalizumab By PBR Staff Writer
Switzerland-based Roche has commenced phase III clinical trials for lampalizumab, an investigational drug for the treatment of geographic atrophy (GA).
Contract Research & Services > Clinical Trials > News
FDA approves Movantik tablets for opioid-induced constipation treatment By PBR Staff Writer
The US Food and Drug Administration (FDA) has approved AstraZeneca’s Movantik tablets C-II as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain.
Production & Manufacturing > Manufacturing > News GSK resolves risk management violation issue at Montana facility in US By PBR Staff Writer
British drug-maker GlaxoSmithKline (GSK) has resolved the issue of Clean Air Act violation, associated with its failure to submit a risk management plan at its facility in Hamilton, Montana, US.
Regulatory Affairs > News US FDA approves Aurobindo’s generic anti-infective drug By PBR Staff Writer
The US Food & Drug Administration (USFDA) has issued final approval to produce and market Aurobindo Pharma’s generic version of Amoxicillin for oral suspension to treat infections in the American market.
Drug Research > Drug Delivery > News

Latest News and Insight by Sector

Production & Manufacturing

FDA approves Movantik tablets for opioid-induced constipation treatment
By PBR Staff Writer
The US Food and Drug Administration (FDA) has approved AstraZeneca’s Movantik tablets C-II as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation in adult patients with chronic, non-cancer pain.
Production & Manufacturing > Manufacturing > News
GSK exercises option for Five Prime’s skeletal muscle disease target
By PBR Staff Writer
GlaxoSmithKline (GSK) has exercised an option to obtain an exclusive license for undisclosed muscle disease treatments developed by Five Prime Therapeutics.
Production & Manufacturing > Manufacturing > News

Drug Research

Lupin and Merck Serono enter into strategic alliance
By PBR Staff Writer
Lupin and Merck Serono have entered into a strategic partnership to support the latter to broaden its general medicines portfolio in emerging markets.
Drug Research > Drug Discovery & Development > News
US FDA approves Aurobindo’s generic anti-infective drug
By PBR Staff Writer
The US Food & Drug Administration (USFDA) has issued final approval to produce and market Aurobindo Pharma’s generic version of Amoxicillin for oral suspension to treat infections in the American market.
Drug Research > Drug Delivery > News

Inward Investment

Endo offers $2.2bn to acquire Auxilium
By PBR Staff Writer
Irish pain drugmaker Endo International has proposed $2.2bn offer to acquire biopharmaceutical company Auxilium Pharmaceuticals.
Inward Investment > News
Cognizant agrees to buy TriZetto for $2.7bn
By PBR Staff Writer
Cognizant has signed a definitive agreement to acquire US-based healthcare IT software and solutions provider TriZetto for $2.7bn in cash.
News

Packaging

Biologics adds frozen storage capabilities to clinical research services
By PBR Staff Writer
Biologics’ Clinical Research Services has announced the addition of frozen storage capabilities to its state-of-the-art facilities and cold-chain packaging and distribution.
Packaging > News
ATMI, D-Lab launch new Sterile Pyrofree vials
By PBR Staff Writer
US-based technology firm ATMI in partnership with Disposable Lab (D-Lab), a French contract-manufacturing company, has launched a line of pyrogen-free vials in order to meet biopharmaceutical filling and final packaging needs.
Packaging > News

Contract Research & Services

Akashi Therapeutics acquires global rights to GsMTx-4 compound
By PBR Staff Writer
Clinical stage biopharmaceutical company Akashi Therapeutics has received global rights to GsMTx-4, a peptide developed by Tonus Therapeutics to address calcium level imbalance in muscle.
Contract Research & Services > Contract Research > News
Roche commences phase III clinical trials for lampalizumab
By PBR Staff Writer
Switzerland-based Roche has commenced phase III clinical trials for lampalizumab, an investigational drug for the treatment of geographic atrophy (GA).
Contract Research & Services > Clinical Trials > News

Automation

HUYA Bioscience, TIPR form JV for new medical technologies in global markets
By PBR Staff Writer
HUYA Bioscience International (HUYA) has entered into a joint venture agreement with Tianjin Institute of Pharmaceutical Research (TIPR) to develop medical technologies and therapies, originating in both China and the western world, for global markets.
Automation > IT & Software > News
NeoStem enters into license deal with Rockefeller University to expand cancer immunotherapy
NeoStem (NBS), a leader in the emerging cellular therapy industry, announced that the Company has entered into an exclusive license agreement with The Rockefeller University for patented technologies that further expand the Company's intellectual property portfolio associated with its Targeted Cancer Immunotherapy Program.
Automation > IT & Software > News

Regulatory Affairs

GSK resolves risk management violation issue at Montana facility in US
By PBR Staff Writer
British drug-maker GlaxoSmithKline (GSK) has resolved the issue of Clean Air Act violation, associated with its failure to submit a risk management plan at its facility in Hamilton, Montana, US.
Regulatory Affairs > News
FDA committee recommends approval of Natpara to treat hypoparathyroidism
NPS Pharmaceuticals, a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases, has announced that the U.S. Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee voted 8 to 5 that the available data support the approval of Natpara (rhPTH [1-84]) for the long-term treatment of Hypoparathyroidism, a rare endocrine disorder characterized by insufficient levels of parathyroid hormone, or PTH.
Regulatory Affairs > News

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Reports Buy online from $250



Data-Label.co.uk DataLabel have been supplying
the medical industry with labels
for over 10 years

Manufactures of
healthcare packaging
machinery